Welcome to our dedicated page for Molina Hlthcare news (Ticker: MOH), a resource for investors and traders seeking the latest updates and insights on Molina Hlthcare stock.
Molina Healthcare Inc. (MOH) delivers managed care solutions for government-sponsored health programs, serving millions through Medicaid, Medicare, and Marketplace plans. This page provides investors and stakeholders with essential updates on operational developments, regulatory compliance, and strategic initiatives shaping this Fortune 500 company's trajectory.
Access timely press releases detailing earnings results, state contract awards, and care delivery innovations. Our repository includes updates on Medicaid expansion efforts, Medicare Advantage plan adjustments, and participation in dual-eligible demonstration projects across 12 states and Puerto Rico.
Key content categories include quarterly financial disclosures, partnership announcements with state agencies, service area expansions, and clinical quality improvement initiatives. All materials are sourced directly from official company communications to ensure reliability.
Bookmark this page for streamlined monitoring of MOH's performance in the $800B+ government healthcare market. Check regularly for updates impacting the company's position in managed care networks and state procurement cycles.
Molina Healthcare (NYSE: MOH) closed a private offering of $850 million aggregate principal amount of 6.500% senior notes due February 15, 2031, with interest accruing from November 20, 2025 and payable semi‑annually on February 15 and August 15 beginning August 15, 2026.
Net proceeds were approximately $838 million after fees and expenses. The company intends to use the net proceeds for general corporate purposes, including repayment of its outstanding delayed draw term loans under its existing credit agreement. The notes were sold under Rule 144A and Regulation S and are not registered under the Securities Act.
Molina Healthcare (NYSE: MOH) priced $850 million of 6.500% senior notes due February 15, 2031 in a Rule 144A/Reg S private offering, expected to close on or about November 20, 2025. Interest accrues from the Settlement Date and is payable semi‑annually on February 15 and August 15, commencing August 15, 2026. The notes will not be guaranteed by subsidiaries at issuance. After fees and expenses, estimated net proceeds are approximately $838 million. The company intends to use the net proceeds for general corporate purposes, including repaying outstanding delayed draw term loans under its credit agreement. The notes are unregistered under the Securities Act and restricted from resale in the U.S.
Molina Healthcare (NYSE: MOH) announced an intended private offering of $750 million aggregate principal amount of senior notes due 2031. The offering will be made under exemptions to the Securities Act, with sales limited to qualified institutional buyers under Rule 144A and certain non-U.S. persons under Regulation S. The notes will not be guaranteed by any subsidiaries at issuance, and interest rate, offering price and other terms are to be determined.
The company intends to use net proceeds to repay outstanding delayed draw term loans under its existing credit agreement. The notes will not be registered under the Securities Act and are subject to customary closing conditions.
Molina Healthcare (NYSE: MOH) said the Florida Agency for Health Care Administration intends to award Molina Healthcare of Florida a contract to serve as the sole plan for Statewide Medicaid Managed Care (SMMC) and CHIP services for the Title XIX/XXI Children’s Medical Services program.
Molina expects to serve approximately 120,000 enrollees. In calendar year 2025, total premiums under the program are expected to be about $5 billion. The contract is expected to run through December 31, 2030, though the official contract start date has not yet been determined.
Molina Healthcare (NYSE: MOH) has scheduled its third quarter 2025 earnings release and conference call. The company will release its Q3 2025 financial results after market close on Wednesday, October 22, 2025.
The earnings conference call and webcast will be held on Thursday, October 23, 2025, at 8:00 a.m. Eastern Time. Investors can access the call by dialing (877) 883-0383 with confirmation number 2660919. A telephonic replay will be available through October 30, 2025, and a 30-day online replay will be accessible on the company's investor relations website.
Molina Healthcare (NYSE:MOH) reported Q2 2025 financial results with mixed performance and revised guidance. The company posted GAAP earnings of $4.75 per share (down 8% YoY) and adjusted EPS of $5.48 (down 6% YoY). Premium revenue increased 15% to $10.9 billion, driven by new contracts, acquisitions, and growth in current markets.
The company experienced challenges with medical cost trends, reporting a Medical Care Ratio (MCR) of 90.4%, up from 88.6% in Q2 2024. Membership grew to 5.7 million, an increase of 167,000 members year-over-year. Molina revised its full-year 2025 guidance, now expecting adjusted earnings of no less than $19.00 per share, while maintaining premium revenue guidance of approximately $42 billion.
Molina Healthcare (NYSE:MOH) has announced preliminary Q2 2025 financial results and revised its full-year guidance. The company expects Q2 2025 adjusted earnings of approximately $5.50 per share, below previous expectations, due to medical cost pressures across all business lines.
Due to anticipated continued cost pressures, MOH has updated its full-year 2025 adjusted earnings guidance to $21.50-$22.50 per share, with a consolidated pre-tax margin just under 4%. CEO Joseph Zubretsky characterized the earnings pressure as temporary, resulting from a dislocation between premium rates and accelerated medical cost trends.
Molina Healthcare (NYSE: MOH) reported strong Q1 2025 financial results with GAAP earnings of $5.45 per diluted share and adjusted earnings of $6.08 per diluted share. Premium revenue increased 12% year-over-year to $10.6 billion, driven by new contract wins, acquisitions, and growth in current markets.
The company served approximately 5.8 million members, up 25,000 from Q1 2024. The Medical Care Ratio (MCR) was 89.2%, with Medicaid at 90.3%, Medicare at 88.3%, and Marketplace at 81.7%. The G&A ratio improved to 6.9%.
Molina reaffirmed its full year 2025 guidance, expecting premium revenue of approximately $42 billion and adjusted earnings of at least $24.50 per diluted share. The company purchased approximately 1.7 million shares for $500 million in Q1 2025.